San Francisco, California – An innovative therapy using a patient’s own stem cells, modified to resist infection with the AIDS virus, has been given approval by the Food and Drug Administration (FDA) to begin a clinical trial in people. CIRM, California’s stem cell agency, is funding that trial. The therapy focuses on a protein found on cells in the immune system. HIV hijacks this protein, using it to penetrate and infect our cells. Researchers at City of Hope near Los… Read more
According to a study published in Nature, a new therapy using antibodies in HIV patients reduced the presence of the virus by up to 300 times. It is the first proof of concept that an antibody-based therapy could be effective in controlling HIV infection according to Barry Zingman, M.D., the Medical Director of the AIDS Center and Clinical Director of Infectious Diseases at Montefiore Medical Center Moses Division. The antibody treatment was injected in varying concentrations in 12 uninfected and… Read more
For the first time, a study shows that a drug used to treat HIV infection also can help prevent it when taken before and after risky sex by gay men.
The results offer hope of a more appealing way to help prevent the disease beyond taking daily pills and using condoms, although those methods are still considered best.
The study, done in France and Canada, is the first to test “on demand” use of Truvada, a pill combining two AIDS drugs, by people planning to have risky sex. The uninfected men who took it were 86 percent less likely to get HIV compared to men given dummy pills.Read More